Although IPTp has been recommended by WHO for nearly two decades, with a target of 80% coverage,
in 2022, among eligible pregnant women, 64% received IPTp1, 54% received IPTp2, and only 42%
received IPTp3, despite the fact that 78% of pregnant wom...